SEL Mfg standalone loss narrows 10% YoY to ₹39.9 Cr as revenue falls 31% on plant shutdown
PAT +9.8% YoY · revenue -31.18% · margins expanding
₹3.66 Cr
-31.18% YoY
₹-39.88 Cr
+9.8% YoY
-1037.62%
-937.6pp YoY
₹-12.04
SEL Manufacturing's Q2 FY27 standalone net loss narrowed 9.8% year-on-year to ₹39.88 Cr (from ₹44.22 Cr), even as revenue from operations collapsed 31.2% YoY to ₹3.66 Cr (from ₹5.31 Cr) — the company's major plants stayed shut through the quarter and operating income now comes almost entirely from job-work at one unit rather than its own manufacturing. Sequentially, revenue rose 21.4% off a low June-quarter base of ₹3.01 Cr and the loss narrowed a further 5.0% from ₹41.99 Cr, but both prints remain structurally lossmaking on a job-work-only revenue base. There is no analyst consensus or brokerage coverage for this stock (confirmed via web search), so vsStreet is unknown; management also carries no formal guidance or outlook on record, so neither can be graded against expectations.
Q2 FY-2027 vs prior quarters
The margin story is the key underlying shift: operating performance (EBITDA-level) is now close to breakeven at roughly -₹0.04 Cr this quarter, versus -₹1.83 Cr in Q1 FY27 and -₹1.21 Cr a year ago — i.e., the job-work model is barely loss-making at the operating line. Nearly the entire net loss instead stems from legacy fixed costs: finance cost of ₹20.04 Cr and depreciation of ₹20.79 Cr, each over five times the quarter's ₹3.66 Cr revenue, reflecting a asset base (₹753.79 Cr net PP&E) built for full-scale manufacturing that is now largely idle. No impairment has been recognised against this idle plant under Ind AS 36 despite the company itself flagging potential impairment indicators (Note 4) — the auditor could not ascertain the impact in the absence of management's impairment testing.
The stock went into the print at ₹29.25, up 6.1% over the past month of trading.
For context: this is the second-highest quarterly PAT of the last 6 quarters.
The filing confirms SEL remains under severe financial stress nearly five years after its NCLT resolution plan was implemented (FY20-21): cumulative losses stand at ₹890.65 Cr, the company has defaulted on ₹413.25 Cr of principal instalments and ₹232.21 Cr of interest due between FY24 and Sep-2026, and auditors flag a material uncertainty on going concern. Separately and concurrently, the Board on 14 Nov 2026 replaced its entire independent-director slate — three directors (including the prior Chairperson) resigned and three new ones were appointed — while the company remains non-compliant on the Company Secretary vacancy since March 2026 and has not paid ₹5.85 lakh of listing fees for FY26 and FY27. None of these governance items directly drove the quarter's numbers but they underline the going-concern and compliance risk the auditor already flagged.
W1
Any resumption of full manufacturing (vs the current job-work-only model) — revenue is currently ₹3.66 Cr/quarter against a much larger idle asset base (₹753.79 Cr net PP&E).
W2
Resolution of the ₹413.25 Cr defaulted principal and ₹232.21 Cr unpaid interest under the NCLT moratorium, and any ruling on the pending declassification application.
W3
Whether Ind AS 36 impairment testing on the idle plant (flagged by both management's Note 4 and the auditor) is finally carried out, which could materially change the asset base and P&L.
Only one financial statement presented (no separate consolidated section); treated as standalone, consistent with comparison context. Exceptional item (₹0.98 Cr this quarter, ₹0.61 Cr year-ago) is a small net gain/write-back reducing the reported loss versus pre-exceptional operating loss — immaterial to the overall story (~2% of loss). Auditor issued a qualified review opinion plus a material uncertainty on going concern.